EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
31 hedge funds and large institutions have $40.2M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
–
Reduced
–
Closed
–
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
+$14K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$6.04M |
| 2 |
LA
Linden Advisors
New York
|
+$4.81M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$3.15M |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$2.92M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$2.65M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
D.E. Shaw & Co
New York
| $322K | +$322K | +33,333 | New |
|
|
WRBC
27
W.R. Berkley Corp
Greenwich,
Connecticut
| $190K | +$190K | +19,650 | New |
|
|
PCM
28
Prelude Capital Management
New York
| $97K | +$97K | +10,000 | New |
|
|
AA
29
Ancora Advisors
Cleveland,
Ohio
| $68K | +$68K | +7,000 | New |
|
|
MI
30
MMCAP International
Grand Cayman,
Cayman Islands
| $2.44K | +$2.44K | +250,000 | New |
|